MichaelJBarnettMD

Radiology • Worcester, MA

Physician

Join to view full profile

Are you Dr. Barnett?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 39 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
55 Lake Ave N
Department of Radiology
Worcester, MA 01655
Phone+1 508-856-5740

Fax+1 508-334-5374
Is this information wrong?

Summary

Dr. Michael Barnett, MD is a board certified radiologist in Worcester, Massachusetts. He is affiliated with UMass Memorial Medical Center.

Education & Training

Los Angeles County-Harbor-UCLA Medical CenterResidency, Radiology-Diagnostic, 1986 - 1987
UMMS-BaystateResidency, Radiology-Diagnostic, 1983 - 1986
Tulane University School of MedicineClass of 1980

Certifications & Licensure

American Board of Radiology Diagnostic Radiology

Publications & Presentations

PubMed

Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival.
Bödör, C., Renneville, A., Smith, M., Charazac, A., Iqbal, S., Etancelin, P., Cavenagh, J., Barnett, M. J., Kramarzová, K., Krishnan, B., Matolcsy, A., Preudhomme, C.,...> ;Haematologica. 2012 Jun
Long-term Follow-up of Patients with Chronic Myeloid Leukemia in Chronic Phase Developing Sudden Blast Phase on Imatinib Therapy.
Tantiworawit, A., Power, M.M., Barnett, M.J., Hogge, D.E., Nantel, S.H., Nevill, T.J., Shepherd, J.D., Song, K.W., Sutherland, H.J., Toze, C.L., Abou-Mourad, Y.R., Nar...> ;Leuk Lymphoma. 2012 Jul
Vincristine-induced vocal cord paralysis in a patient with acute lymphoblastic leukemia.
Bacon, L.C., Barnett, M.J., Abou Mourad, Y.R.> ;Ann Hematol. 2012 Jun
Response to tyrosine kinase inhibitor therapy in patients with chronic myelogenous leukemia relapsing in chronic and advanced phase following allogeneic hematopoietic ...
Wright, M.P., Shepherd, J.D., Barnett, M.J., Nantel, S.H., Sutherland, H.J., Toze, C.L., Hogge, D.E., Nevill, T.J., Song, K.W., Abou Mourad, Y.R., Narayanan, S., Power...> ;Biol Blood Marrow Transplant. 2010 May
IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation.
Nevill, T.J., Shepherd, J.D., Sutherland, H.J., Abou Mourad, Y.R., Lavoie, J.C., Barnett, M.J., Nantel, S.H., Toze, C.L., Hogge, D.E., Forrest, D.L., Song, K.W., Power...> ;Biol Blood Marrow Transplant. 2009-02-01
Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy.
Owen, C.J., Toze, C.L., Koochin, A., Forrest, D.L., Smith, C.A., Stevens, J.M., Jackson, S.C., Poon, M., Sinclair, G.D., Leber, B., Johnson, P.E., Macheta, A., Yin, J....> ;Blood. 2008 Dec 1
Philadelphia-negative clonal hematopoiesis following imatinib therapy in patients with chronic myeloid leukemia: a report of nine cases and analysis of predictive fact...
Lin, Y., Bruyère, H., Horsman, D. E., Pantzar, T., Barnett, M. J., Hogge, D. E., Nevill, T. J., Nantel, S. H., Sutherland, H. J., Toze, C. L., Shepherd, J. D., Lavoie,...> ;Cancer Genet Cytogenet. 2006 Oct 1
Early stem cell transplantation for refractory acute leukemia after salvage therapy with high-dose etoposide and cyclophosphamide.
Johny, A., Song, K.W., Nantel, S.H., Lavoie, J.C., Toze, C.L., Hogge, D.E., Forrest, D.L., Sutherland, H.J., Le, A., Nitta, J.Y., Barnett, M.J., Smith, C.A., Shepherd,...> ;Biol Blood Marrow Transplant. 2006 Apr
High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a compari...
Forrest, D.L., Hogge, D.E., Nevill, T.J., Nantel, S.H., Barnett, M.J., Shepherd, J.D., Sutherland, H.J., Toze, C.L., Smith, C.A., Lavoie, J.C., Song, K.W., Voss, N.J.,...> ;J Clin Oncol. 2005 Nov 1
High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treate...
> ;Blood. 2005 Aug 15
Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
Warkentin, D.I., Epstein, J.B., Campbell, L.M., Yip, J.G., Cox, V.C., Ransier, A., Barnett, M.J., Marra, F.> ;Ann Pharmacother. 2002 Oct
Influence of cytogenetic abnormalities on outcome after allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission.
Chalandon, Y., Barnett, M.J., Horsman, D.E., Conneally, E.A., Nantel, S.H., Nevill, T.J., Nitta, J., Shepherd, J.D., Sutherland, H.J., Toze, C.L., Hogge, D.E.> ;Biol Blood Marrow Transplant. 2002
A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma.
Harvey, V. J., Slevin, M. L., Cheek, S. P., Barnett, M. J., Gregory, W., Thompson, J. P., Wrigley, P. F.> ;Eur J Cancer Clin Oncol. 1987 Nov
Detection of early human T-cell lymphotropic virus type I antibody patterns during seroconversion among transfusion recipients.
Manns, A., Murphy, E. L., Wilks, R., Haynes, G., Figueroa, J. P., Hanchard, B., Barnett, M., Drummond, J., Waters, D., Cerney, M.> ;Blood. 1991 Feb 15
A follow up study of patients with paraneoplastic neurological disease in the United Kingdom.
Candler, P. M., Hart, P. E., Barnett, M., Weil, R., Rees, J. H.> ;J Neurol Neurosurg Psychiatr. 2004 Oct
Iron overload in beta-thalassaemia minor. A family study.
Parfrey, P. S., Barnett, M., Sachs, J. A., Pollock, D. J., Turnbull, A. L.> ;Scand J Haematol. 1981 Oct
Spectrum of HTLV-III infection in a hemophilic cohort treated with blood products from a single manufacturer.
McGrath, K. M., Spelman, D., Barnett, M., Kellner, S.> ;Am J Hematol. 1986 Nov
Length of stay as a source of bias in comparing performance in VA and private sector facilities: lessons learned from a regional evaluation of intensive care outcomes.
Kaboli, P. J., Barnett, M. J., Fuehrer, S. M., Rosenthal, G. E.> ;Med Care. 2001 Sep
Early adopters of olestra-containing foods: who are they?
Neumark-Sztainer, D., Kristal, A. R., Thornquist, M. D., Patterson, R. E., Neuhouser, M. L., Barnett, M. J., Rock, C. L., Cheskin, L. J., Schreiner, P., Miller, D. L.> ;J Am Diet Assoc. 2000 Feb
Bone marrow transplantation in the treatment of Hodgkin''s lymphoma: problems, remaining challenges, and future prospects.
Armitage, J. O., Barnett, M. J., Carella, A. M., Dicke, K. A., Diehl, V., Gribben, J. G., Pfreundschuh, M.> ;Recent Results Cancer Res. 1989
Enantioselective induction of cyclophosphamide metabolism by phenytoin.
Williams, M. L., Wainer, I. W., Embree, L., Barnett, M., Granvil, C. L., Ducharme, M. P.> ;Chirality. 1999
Adult acute myeloid leukaemia.
Smith, M., Barnett, M., Bassan, R., Gatta, G., Tondini, C., Kern, W.> ;Crit Rev Oncol Hematol. 2004 Jun
A phase 2 study of surveillance in patients with metastatic renal cell carcinoma and assessment of response of such patients to therapy on progression.
Oliver, R. T., Miller, R. M., Mehta, A., Barnett, M. J.> ;Mol Biother. 1988
bcr rearrangement and translocation of the c-abl oncogene in Philadelphia positive acute lymphoblastic leukemia.
De Klein, A., Hagemeijer, A., Bartram, C. R., Houwen, R., Hoefsloot, L., Carbonell, F., Chan, L., Barnett, M., Greaves, M., Kleihauer, E.> ;Blood. 1986 Dec
The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle.
Harvey, V. J., Slevin, M. L., Woollard, R. C., Johnston, A., Barnett, M. J., Wrigley, P. F., Turner, P.> ;Cancer Chemother Pharmacol. 1984
Join now to see all

Press Mentions

Artificial Intelligence to Improve Medical Imaging for Patients with Brain AilmentsAugust 2nd, 2018

Hospital Affiliations

UMass Memorial Medical CenterWorcester, Massachusetts